Displaying drugs 1476 - 1500 of 1794 in total
PF-06305591
Pf 06305591 is under investigation in clinical trial NCT01776619 (Safety and Tolerability Study of Multiple Doses of PF-06305591).
Investigational
Meldonium
Experimental
Eprazinone
Eprazinone (trade name Eftapan) is a mucolytic drug, and relieves bronchospasms.
Experimental
Withdrawn
Harmaline
Experimental
Lobeline
An alkaloid that has actions similar to nicotine on nicotinic cholinergic receptors but is less potent. It has been proposed for a variety of therapeutic uses including in respiratory disorders, peripheral vascular disorders, insomnia, and smoking cessation. [PubChem]
Investigational
2,3-Didehydroalanine
Experimental
Apolizumab
Apolizumab is a humanized monoclonal antibody that is being studied as a treatment for hematologic cancers.
Investigational
N-Acetyl-Serine
Experimental
2-Amino-3-Oxo-4-Sulfo-Butyric Acid
Experimental
Maltotetraose
Experimental
Vinburnine
Experimental
Tetragalacturonic acid hydroxymethylester
Experimental
alpha-L-iduronic acid
Experimental
(3R)-3-HYDROXYDODECANOIC ACID
Experimental
L-tartaric acid
Tartaric acid is a white crystalline organic acid that occurs naturally in many plants, most notably in grapes.Tartaric is an alpha-hydroxy-carboxylic acid, is diprotic and aldaric in acid characteristics, and is a dihydroxyl derivative of succinic acid.
Experimental
L-threonic acid
Experimental
LGD-1550
LGD-1550 is an orally-active synthetic aromatic retinoic acid agent with potential antineoplastic and chemopreventive activities.
Investigational
D-pantetheine 4'-phosphate
Experimental
TETRAHEDRAL INTERMEDIATE OF BLASTICIDIN S
Experimental
Displaying drugs 1476 - 1500 of 1794 in total